InnovAge Holding Corp. Form 8-K Summary
Business Context and Reporting Period
InnovAge Holding Corp. filed a Form 8-K dated November 12, 2021, reporting the appointment of Patrick Blair as President, effective December 1, 2021. The filing concerns a management change and related compensation arrangements; it does not report quarterly or annual financial results.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.
Material Changes Versus the Prior Comparable Period
- Patrick Blair was appointed President, reporting directly to the Board.
- He will initially oversee center operations, clinical functions, human capital, technology, sales and marketing, and center development, with additional responsibilities expected over time.
- The filing does not quantify any resulting change to the company’s financial outlook or operations.
Compensation, Outlook, Risks, and Unusual Items
- Annual base salary: $750,000.
- Target discretionary annual bonus: 100% of base salary, subject to Board discretion and company performance.
- One-time cash sign-on bonus: $600,000.
- Equity awards valued using the November 10, 2021 closing stock price: options valued at $10.5 million and restricted stock units valued at $3.5 million. The filing text does not provide the resulting share counts or option exercise price.
- For each equity award, 41⅔% is subject to time vesting, 41⅔% is conditioned on the stock price reaching at least $15.00 per share, and 16⅔% is conditioned on the stock price reaching at least $21.00 per share.
- If Mr. Blair is terminated without cause or resigns for good reason, subject to a release and other conditions, severance includes 24 months of base salary, two times his target annual bonus, and 18 months of company-paid healthcare coverage.
- No management guidance or broader business outlook was provided.
- The filing states that there are no arrangements with other persons relating to the appointment, no applicable family relationships, and no related-person transactions.
Key Facts for Investors to Verify
- Review Exhibit 10.1 for the complete employment agreement, vesting provisions, termination definitions, and severance terms.
- Verify the November 10, 2021 closing stock price and the resulting number of options and RSUs.
- Assess the potential dilution and compensation expense associated with the equity awards.
- Monitor implementation of the new President’s operational responsibilities and any subsequent financial or operating guidance.